Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial-Reference-Cited by-同舟云学术

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

Published:2003-01 Issue:1 Volume:61 Page:119-126
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Kirby Roger S,Roehrborn Claus,Boyle Peter,Bartsch Georg,Jardin Alain,Cary Margaret M,Sweeney Michael,Grossman Eric B

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. The development of human benign prostatic hyperplasia with age;Berry;J Urol,1984

2. Natural history, evaluation, and nonsurgical management of benign prostatic hyperplasia;Lepor,1998

3. Doxazosin treatment in patients with prostatic obstruction;Christensen;Scand J Urol Nephrol,1993

4. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients;Fawzy;J Urol,1995

5. Tamsulosin, a selective α1c-adrenoceptor antagonist;Abrams;Br J Urol,1995

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS);The Prostate;2024-01-09

2. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Expert Opinion on Drug Safety;2023-12-02

3. Medical Management of Benign Prostatic Hyperplasia;Men's Reproductive and Sexual Health Throughout the Lifespan;2023-11-16

4. Konservative und medikamentöse Therapie des benignen Prostatasyndroms;Die Urologie;2023-10

5. Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance;Minerva Urology and Nephrology;2023-08